David Armstrong – Trademark Portfolio

Entity Type: 01

David Armstrong holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include VIBRACLEAR and ARMSTRONG METABOLIC. The owner is based in Laguna Hills, CA.

25411 Cabot Road

Laguna Hills, CA 92653

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

David Armstrong's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does David Armstrong have?

David Armstrong has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does David Armstrong file in?

David Armstrong files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are David Armstrong's most well-known trademarks?

David Armstrong's registered trademark portfolio includes well-known marks such as VIBRACLEAR and ARMSTRONG METABOLIC. These are among 2 currently registered trademarks in the portfolio.

What is David Armstrong's trademark registration success rate?

David Armstrong has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.